There’s no single sign that tells you chemotherapy is working. Your oncology team uses a combination of imaging scans, blood tests, physical exams, and your own symptom reports to build a picture of how your cancer is responding to treatment. Most people won’t get their first formal assessment until they’ve completed two or three cycles of chemo, which can mean weeks of uncertainty. Here’s what your care team is actually looking for and what you can track on your own.
Imaging Scans: The Most Direct Measure
CT scans, MRIs, and PET scans are the primary tools for measuring whether tumors are shrinking. Doctors typically order the first follow-up scan after two to three cycles of chemotherapy, though the exact timing depends on your cancer type and treatment plan. Waiting can feel agonizing, but scanning too early can produce misleading results.
When your doctor reads the scan, they’re comparing tumor measurements to your baseline images using a standardized scoring system. The possible outcomes break down into four categories:
- Complete response: All visible signs of the tumor have disappeared. Any remaining lymph nodes measure less than 10 mm.
- Partial response: Tumors have shrunk by at least 30% in diameter compared to the original measurements.
- Stable disease: The tumor hasn’t grown or shrunk enough to qualify as either a response or progression. This can still be a positive outcome, especially for aggressive cancers where the goal is to keep the disease from advancing.
- Progressive disease: The tumor has grown or new tumors have appeared.
Your oncologist will share these results in plain terms, but understanding the categories helps you ask better questions. A partial response after just two cycles, for example, is often very encouraging and may signal that the treatment plan is a good fit.
Why a Scan Can Be Misleading
Sometimes a scan looks worse before things actually improve. This phenomenon, called pseudoprogression, happens when immune cells and inflammatory responses flood the tumor site after treatment. On a scan, this inflammation can look like the tumor is growing or new spots are forming, even though the treatment is actually working.
Pseudoprogression is especially common with immunotherapy but can also occur with standard chemotherapy and radiation. If your doctor suspects it, they may recommend continuing treatment and rescanning in a few weeks rather than immediately switching drugs. Specialized imaging techniques, like perfusion-weighted MRI, can help distinguish real tumor growth (which creates new blood vessels) from inflammation (which does not). If your scan shows apparent worsening but you feel physically better, bring that up with your care team. Clinical symptoms and imaging don’t always tell the same story at the same time.
Blood Tests and Tumor Markers
For certain cancers, a simple blood draw can provide an early signal of how treatment is going. These tests measure proteins or other substances that some cancers release into the bloodstream. When chemo is working, marker levels typically drop. When the cancer is growing or returning, levels rise.
The most commonly tracked tumor markers include:
- CA-125 for ovarian cancer
- CEA (carcinoembryonic antigen) for colorectal cancer
- PSA (prostate-specific antigen) for prostate cancer
Tumor markers are useful but imperfect. Not every cancer produces a measurable marker, and some markers can fluctuate for reasons unrelated to treatment, including infection, inflammation, or even certain foods. Your doctor will never rely on a marker alone to determine whether chemo is working. They use it as one data point alongside imaging and your physical condition. A steadily declining marker over several blood draws is a much stronger signal than any single reading.
Physical Symptoms You Can Track
Between scans and blood tests, your own body offers clues. These aren’t definitive on their own, but your oncology team will ask about them and factor them into the overall assessment.
Positive signs that treatment may be working include a reduction in cancer-related pain, improved appetite, more energy, less shortness of breath, or a noticeable decrease in the size of any lumps you can feel through the skin. If your cancer caused specific symptoms before treatment (a persistent cough from lung cancer, abdominal bloating from ovarian cancer, difficulty swallowing from esophageal cancer), improvement in those symptoms is a meaningful signal.
It’s important to separate chemo side effects from cancer symptoms. You can feel terrible from the treatment itself while the cancer is actually responding well. Nausea, fatigue, and hair loss are signs that chemotherapy is affecting fast-growing cells throughout your body, not indicators of whether it’s hitting the tumor. Feeling worse during treatment doesn’t mean the cancer is winning, and feeling fine doesn’t guarantee the chemo is working. This is exactly why objective measurements like scans and bloodwork matter so much.
What Happens After Surgery
If you receive chemotherapy before surgery (called neoadjuvant treatment), there’s one more way to assess how well it worked. After the tumor is removed, a pathologist examines the tissue under a microscope for any remaining cancer cells. The best possible result is a pathologic complete response, meaning no living cancer cells are found in the surgical specimen. This is a strong indicator that treatment was effective and is associated with better long-term outcomes for many cancer types.
Even if some cancer cells remain, the pathologist can estimate what percentage of the tumor was destroyed. A near-complete response, where only scattered cells survived, is still a favorable sign. Your surgeon and oncologist will use these findings to decide whether you need additional treatment after surgery.
The Typical Timeline for Answers
The hardest part for many patients is the wait. Here’s a general sense of when you can expect information:
Blood tumor markers, if applicable to your cancer, are often checked before each treatment cycle. You may see trends within the first few weeks. Imaging scans are typically scheduled after every two to three cycles, which translates to roughly six to nine weeks for most chemotherapy regimens. Your doctor may adjust this schedule based on how aggressive your cancer is, how you’re tolerating treatment, or whether symptoms are changing rapidly.
After completing a full course of chemotherapy (commonly six cycles for many cancers), you’ll have a comprehensive restaging evaluation. This usually involves imaging one to two months after the final cycle, giving your body time to recover and allowing treatment effects to fully manifest on scans. From that point, follow-up imaging continues at regular intervals to watch for recurrence.
What “Working” Actually Means
It helps to understand that “working” doesn’t always mean “curing.” The goal of chemotherapy varies depending on your situation. For early-stage cancers, the aim is often to eliminate the disease entirely or to shrink a tumor before surgery. For advanced cancers, the goal may be to slow progression, relieve symptoms, and extend life. In that context, stable disease on a scan is a win.
If your first scan shows the cancer hasn’t responded, that doesn’t mean all treatment has failed. It means this particular drug combination isn’t the right fit, and your oncologist will recommend alternatives. Many people go through more than one chemo regimen before finding the one that works for their cancer. The key is that your team is reassessing regularly and making adjustments based on real data, not guesswork.